Home > Products > B Cell Lymphoma 38C13 Idiotype & LFA-1 > Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (Tandem Diabody)

Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (Tandem Diabody)  (CAT#: T-BSDB-014)

Recombinant Anti-B cell lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (Tandem Diabody) is designed to be expressed as a monomeric subunit (single chain Diabody, scDb), with four variable domains from two parental antibodies. Then the two peptide chains can dimerize in a head-to-tail fashion. This BsAb can block cell adhesion. It is designed for the research of B cell lymphoma therapy.
Datasheet INQUIRY

Specifications

Targets
B Cell Lymphoma 38C13 Idiotype & LFA-1
Species Reactivity
Mouse
Application
FuncS; Promising therapeutic agent
Related Disease
B cell lymphoma

Targets

Target 1
B Cell Lymphoma 38C13 Idiotype
Alternative Names
B cell lymphoma 38C13 Idiotype; B cell lymphoma; 38C13 ; Idiotype; Id
Target 2
LFA-1
Gene ID
UniProt ID
Alternative Names
integrin subunit alpha L; Integrin beta chain-2; ITGB2; Integrin subunit beta 2; MF17, MAC-1; ITGAL; CD11A; LFA-1; LFA1A; ITGAL; CD18; LCAMB; AI528527; 2E6; LAD
Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.
Online Inquiry

See other bsAb targets related to "B Cell Lymphoma 38C13 Idiotype"

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-B Cell Lymphoma 38C13 Idiotype x Anti-LFA-1 Bispecific Antibody (Tandem Diabody) (T-BSDB-014). Click the button below to contact us or submit your feedback about this product.